Articles On Recce Pharmaceuticals (ASX:RCE)

The Recce Pharmaceuticals Ltd (ASX: RCE) share price has been a positive performer on Tuesday. In morning trade, the pharmaceutical company’s shares are up 3.5% to $1.17. This latest gain means the Recce Pharmaceuticals share price has now...

Recce Pharmaceuticals (ASX:RCE) has announced that its RECCE 327 has demonstrated bactericidal activity against all six antibiotic-resistant ESKAPE pathogens, including drug-resistant mutations as well as two additional WHO priority...

Mixed start to the month on Wall Street Wall Street was mixed, with the Dow Jones and S&P500 indices rising by 0.70% and 0.275 respectively, while tech heavy NASDAQ was down by 0.48%. Broadly speaking, investors ditched technology, fina...

The Recce Pharmaceuticals Ltd (ASX: RCE) share price is slipping today after the company released its quarterly activities report. At the time of writing, the Recce share price is down 1.85% to $1.06 per share. Recce is a drug discovery a...

15 Apr 2021 - Recce Pharmaceticals’ (ASX:RCE) lead compound RECCE® 327 has been registered in the Australian New Zealand Clinical Trial Registry (ANZCTR) for its Phase I/II Topical…

Recce Pharmaceuticals Ltd (ASX: RCE) shares are on the move in mid-afternoon trade. This comes after the company announced the inclusion of Recce 327 into the Australian New Zealand Clinical Trial Registry (ANZCTR). At the time of writing,...

The first person formally treated with Recce Pharmaceutical’s (ASX:RCE) next-generation antibiotic calls it a “bloody miracle” after it cured a chronic, debilitating sinus infection he had suffered from for decades. Fletcher, a 59-year-old...

Recce Pharmaceuticals (ASX:RCE) has announced that a SAS Category A notification has been made to the TGA by a medical practitioner following the successful treatment of a patient with RECCE 327.

The Recce Pharmaceuticals Ltd (ASX: RCE) share price rose 7% this morning after the company shared good news of its drug, RECCE 327 (R327). The gains come on the back of the successful treatment of a terminally ill human with the antivirus...

Apr 2021 - Superbug and viral pathogen treatment developer Recce Pharmacetical (ASX:RCE)’s unapproved drug R327 has successfully saved a patient suffering a life-threatening illnes…

In late morning trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another decent gain. At the time of writing, the benchmark index is up 0.5% to 6,919.6 points. Four ASX shares that are climbing more than most today are li...

Recce Pharmaceuticals Ltd [ASX:RCE] is a prime example. With the stock trading 0.5% lower at time of writing. Suffering a mixed day of trading as its share price has jumped up and down... The post Recce Pharmaceuticals Shares Up on Positive...

The Recce Pharmaceuticals Ltd (ASX: RCE) share price has spent today in the red despite the company releasing positive data from anti-infective drug trials against bacterial sinusitis in mice. It seems shareholders weren’t excited by the r...

Source:Guschenkova, Shutterstock Summary Recce Pharmaceutical disclosed that data from an animal study demonstrated the positive efficacy of its new anti-infective formulation RECCE® 111. The Company’s R327 and R111 compounds showed s...

The Recce Pharmaceuticals Ltd (ASX: RCE) share price is pushing higher on Monday morning. At the time of writing, the synthetic anti-infectives focused biotechnology company’s shares are up 3% to $1.01. Why is the Recce share price pushing...

Source: Shutterstock Summary ASX-listed world-leader in synthetic-polymer antibiotics Recce Pharmaceuticals to list its stocks on the FSE. The listing will broaden the investor base and enable access to additional capital markets. Re...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a decline. At the time of writing, the benchmark index is down 0.2% to 6,836.4 points. Four ASX shares that are not letting that hold them back ar...

The Recce Pharmaceuticals Ltd (ASX: RCE) share price has been on fire on Friday morning. At the time of writing, the drug discovery and development company’s shares are up over 10% to $1.14. This means the Recce share price is now up 180%...

Summary Recce Pharmaceuticals announces positive animal data for its products RECCE® 327 and RECCE® 529 against the SARS-CoV-2 virus. The internasal administration indicates that the products can be administered in several ways. The C...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to bounce back from yesterday’s drop. At the time of writing the benchmark index is up 0.9% to 6,658.2 points. Four shares that are climbing more than most today are l...

The Recce Pharmaceuticals Ltd (ASX: RCE) share price is pushing higher on Wednesday after the release of an announcement. In morning trade the pharmaceutical company’s shares are up 4% to $1.12. Why is the Recce share price pushing higher?...

Summary The near-festive season and recent relaxation in restrictions are having a positive effect on consumer sentiments. Woolworth’s 1Q2021 report indicates a significant increase in e-commerce sales. Recce Pharmaceutical’s RECCE® 3...

26 Nov 2020 - Recce Pharmaceuticals Ltd (ASX:RCE) has been awarded over $17 million of Synthetic Antibiotic Research & Development applicable expenditure by AusIndustry.

The Recce Pharmaceuticals Ltd (ASX: RCE) share price is shooting up today, after the company announced that it has been granted a patent for its Recce 327 and 529 formulations from the Japanese Patent Office (JPO). At the time of writing,...

The company is pioneering the development and commercialisation of new classes of synthetic anti-infectives designed to address the urgent global health problems of antibiotic resistant superbugs and emerging viral pathogens.

The Recce Pharmaceuticals Ltd (ASX: RCE) share price has been soaring up today. Recce shares jumped up more than 14% on news that the company has seen encouraging results in the treatment against the COVID-19 virus. The release comes on th...

Presenting companies were Cynata Therapeutics Ltd, Recce Pharmaceuticals Ltd and Pharmaxis Ltd (ASX:PXS).

Shareholders in Recce Pharmaceuticals Ltd (ASX: RCE) have been hitting the sell button today following the release of its quarterly update. At the time of writing, the Recce share price is trading 7.59% lower at $1.10. This represents a de...

2020 has been a busy year for Recce Pharmaceuticals Ltd [ASX:RCE]. The biotech small-cap has been tirelessly putting their synthetic anti-infectives to the test. However, as with any new medicine or treatment, they must first pass intensive...

The Recce Pharmaceuticals Ltd (ASX: RCE) share price is rocketing higher today following an update on its Recce 327 product. In early trade, the medical company’s share price hit an intra-day high of $1.19, but has since retreated to $1.12...

By Peter Switzer, Switzer Report Lots of smaller companies I like One thing I’ve personally learnt this year is the power of small cap companies to drive your portfolio’s value higher. This revelation makes me even more committed to the ide...

The market may be dropping lower on Wednesday, but that hasn’t stopped the Recce Pharmaceuticals Ltd (ASX: RCE) share price from jumping higher. In afternoon trade the pharmaceutical company’s shares are up almost 10% to $1.21. This latest...

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a sizeable decline. At the time of writing the benchmark index is down 0.8% to 5,903.3 points. Four shares that have not let that hold them back are liste...

30 Sep 2020 - Recce Pharmaceuticals (ASX:RCE) has entered into an agreement with the Murdoch Children’s Research Institute to conduct pre-clinical studies assessing the potential o…

The Recce Pharmaceuticals Ltd (ASX: RCE) share price has come under pressure on Wednesday after returning from its trading halt. The pharmaceutical company’s shares crashed as much as 15% lower to $1.38 this morning. They have since recove...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a very strong gain. At the time of writing the benchmark index is up 1.6% to 5,878.5 points. Four shares that have failed to follow the market higher today a...

While everyone has been busy looking at buy now, pay later (BNPL) shares, there are plenty of other ASX shares that have also grown considerably since the start of the year. Each of the following companies has developed a solid foundation...

Shaw and Partners is pleased to be appointed as Lead Manager to an equity capital raising by Recce Pharmaceuticals Ltd (ASX.RCE)   The company is undertaking an instituti... Read More

Global investment giant Fidelity is poised to storm up the register of small cap listed drug developer Recce Pharmaceuticals.

Active investing will earn greater returns in a volatile market. That’s not just my opinion, but a view in the Australian Financial Review back in 2018. Moreover, I believe active management in growth investing is always more effective. Th...

The Sydney-based biotechnology company recently announced a phase 1 trial aimed at new classes of synthetic anti-infectives. At the time of writing the Recce Pharmaceuticals Ltd [ASX:RCE]  share price is up 4.40%, to trade at $1.66, on the...

Today has been very strong for a range of ASX sectors after yesterday’s market fall. We’ve seen the share prices of a number of innovative ASX growth companies rise today, including the 3 listed below. DroneShield Ltd (ASX: DRO) The Drone...

The Australian share market was on form on Tuesday and stormed notably higher again. While a good number of shares climbed higher with the market, a few climbed more than most. In fact, some climbed so much they reached new highs. Two whic...

I’m a big believer in investing in quality ASX growth shares. If you had picked up Afterpay Ltd (ASX: APT) shares three years ago and held onto them until today, you would be up over 2000%. That means your initial $5,000 investment would g...

Right now investors have a range of areas to choose great ASX shares for growth. On one hand we see radical changes in short term credit with the buy now, pay later companies led by Afterpay Ltd (ASX: APT). On the other hand, changes in th...

Money Talks is Stockhead’s regular drill down into the sectors and companies that investors have their eye on right now. Today, we hear from Lincoln Liu, associate director, Investment Banking of Rawson Lewis. Australia’s biotech sector is...

The Recce Pharmaceuticals Ltd (ASX: RCE) share price traded nearly 15% higher this morning after the company announced positive oral data. What new data has Recce released? Recce Pharmaceuticals released an announcement earlier today which...

A 10-bagger share is one that will return 10 times the initial investment. Over the past decade, there have been many growth shares on the ASX that have multiplied their initial share price 10 times or even 100 times. Unfortunately, while...

Last week, Recce Pharmaceuticals Ltd [ASX:RCE] had a major win. This tiny biocap stock divulged that it was going to be working with the CSIRO on tests. Analysing their anti-infectives in the fight against COVID-19... The post Recce Pharmac...

A quick wrap of the ASX’s key winners and losers on Thursday, July 16. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 604 stocks rose, 684 de...